Shanghai Children‘s Medical Center

undefined

ZHOU Binbing

Professor

SuperviGraduate Supervisor

Shanghai Children’s Medical Center

Research area: Preclinical Medicin

Email: zhoubinbing@scmc.com.cn

Tel: 021-

Research Interests

  • Dr. Zhou has over twenty-five years’ experience in cancer drug resistance and drug discovery. During his tenure in industry, he has contributed to the discovery and/or development of INCB7839 (Phase Ib/II, Cancer Cell 2006), ispenisib (Phase II), and inotuzumabozogamicin (approved). In academic community, Dr. Zhou contributed to the early concept of DNA damage response in collaboration with Dr. Steve Elledge (DDR, Nature 2000, Nature Review Cancer 2004). After joining Shanghai Children’s Medical Center (SCMC) in 2013, his research interests include childhood leukemia clonal evolution, DDR and purine biosynthesis pathway during leukemia relapse (Nature Medicine 2015; Leukemia, 2019, Blood, 2020; Nature Cancer, 2021).